Approval · Notice of Compliance 19404 · 2017
XERESE: Notice of Compliance 19404
Issued June 9, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19404
- Date
- June 9, 2017
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update package insert, (consumer information) carton and tube labels. no changes to pm were proposed and no clinical review was required
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XERESE | Not yet assigned | — |
Medicinal ingredients
- ACYCLOVIR 0.05 G per G
- HYDROCORTISONE 0.01 G per G